Soya protein does not affect glycaemic control in adults with type 2 diabetes

British Journal of Nutrition

Volumn 103, Issue 3, 2010, Pages 412-421

  Gobert, Colleen P ^a   Pipe, Elizabeth A ^a   Capes, Sarah E ^b   Darlington, Gerarda A ^a   Lampe, Johanna W ^c   Duncan, Alison M ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b VANCOUVER ISLAND HEALTH AUTHORITY   (Canada)

^c USA   (United States)

Author keywords

Glycaemic control; Isoflavones; Soya protein; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; ISOFLAVONE; MILK PROTEIN; PLACEBO; SOYBEAN PROTEIN; GLYCOSYLATED HEMOGLOBIN; ISOFLAVONE DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DIET THERAPY; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; URINARY EXCRETION; BLOOD; CALORIC INTAKE; DRUG EFFECT; GLUCOSURIA; HYSTERECTOMY; MEDICAL RECORD; METABOLISM; MIDDLE AGED; POSTMENOPAUSE; SAMPLE SIZE; SECRETION; URINE;

ANIMALIA;

ADULT; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DIET RECORDS; DOUBLE-BLIND METHOD; ENERGY INTAKE; FEMALE; GLYCOSURIA; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYSTERECTOMY; INSULIN; ISOFLAVONES; MALE; MIDDLE AGED; MILK PROTEINS; POSTMENOPAUSE; POSTPRANDIAL PERIOD; SAMPLE SIZE; SOYBEAN PROTEINS;

EID: 77449148993     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114509991802     Document Type: Article

References (67)

1. Zimmet P, Alberti KG & Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 414, 782-787.
2. Zimmet P, Magliano D, Matsuzawa Y, et al. (2005) The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb 12, 295-300.
3. Pradhan A (2007) Obesity, metabolic syndrome, and type 2 diabetes: inflammatory basis of glucose metabolic disorders. Nutr Rev 65, S152-S156.
4. Alberti G, Zimmet P, Shaw J, et al. (2004) Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop. Diabetes Care 27, 1798-1811.
5. King H, Aubert RE & Herman WH (1998) Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21, 1414-1431.
6. O'Brien JA, Patrick AR & Caro JJ (2003) Cost of managing complications resulting from type 2 diabetes mellitus in Canada. BMC Health Serv Res 3, 7.
7. Bavenholm PN & Efendic S (2006) Postprandial hyperglycae-mia and vascular damage-the benefits of acarbose. Diab Vasc Dis Res 3, 72-79.
8. Dawson KG, Gomes D, Gerstein H, et al. (2002) The economic cost of diabetes in Canada, 1998. Diabetes Care 25, 1303-1307.
9. Committee CDACPGE (2003) Canadian Diabetes Association 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can J Diab 27, S1-S152.
10. Stratton IM, Adler AI, Neil HA, et al. (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br Med J 321, 405-412.
11. Gaede P, Vedel P, Larsen N, et al. (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348, 383-393.
12. Krook A, Holm I, Pettersson S, et al. (2003) Reduction of risk factors following lifestyle modification programme in subjects with type 2 (non-insulin dependent) diabetes mellitus. Clin Phy-siol Funct Imaging 23, 21-30.
13. Garg A, Bantle JP, Henry RR, et al. (1994) Effects of varying carbohydrate content of diet in patients with non-insulin-dependent diabetes mellitus. JAMA 271, 1421-1428.
14. Chandalia M, Garg A, Lutjohann D, et al. (2000) Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. N Engl J Med 342, 1392-1398.
15. Sierra M, Garcia JJ, Fernandez N, et al. (2002) Therapeutic effects of psyllium in type 2 diabetic patients. Eur J Clin Nutr 56, 830-842.
16. Mooradian AD, Failla M, Hoogwerf B, et al. (1994) Selected vitamins and minerals in diabetes. Diabetes Care 17, 464-479.
17. Robertson MD, Jackson KG, Fielding BA, et al. (2002) Acute effects of meal fatty acid composition on insulin sensitivity in healthy post-menopausal women. Br J Nutr 88, 635-640.
18. Paniagua JA, de la Sacristana AG, Sanchez E, et al. (2007) A MUFA-rich diet improves posprandial glucose, lipid and GLP-1 responses in insulin-resistant subjects. J Am Coll Nutr 26, 434-444.
19. Fujimoto WY, Leonetti DL, Kinyoun JL, et al. (1987) Prevalence of diabetes mellitus and impaired glucose tolerance among second-generation Japanese-American men. Diabetes 36, 721-729.
20. Fujimoto WY, Leonetti DL, Bergstrom RW, et al. (1991) Glucose intolerance and diabetic complications among Japaese-American women. Diabetes Res Clin Pract 13, 119-129.
21. Goodman-Gruen D & Kritz-Silverstein D (2001) Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J Nutr 131, 1202-1206.
22. Villegas R, Gao YT, Yang G, et al. (2008) Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women's Health Study. Am J Clin Nutr 87, 162-167.
23. Yang G, Shu XO, Jin F, et al. (2004) Soyfood consumption and risk of glycosuria: a cross-sectional study within the Shanghai Women's Health Study. Eur J Clin Nutr 58, 615-620.
24. Lavigne C, Marette A & Jacques H (2000) Cod and soy proteins compared with casein improve glucose tolerance and insulin sensitivity in rats. Am J Physiol Endocrinol Metab 278, E491-E500.
25. Ascencio C, Torres N, Isoard-Acosta F, et al. (2004) Soy protein affects serum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats. J Nutr 134, 522-529.
26. Veloso RV, Latorraca MQ, Arantes VC, et al. (2008) Soybean diet improves insulin secretion through activation of cAMP/ PKA pathway in rats. J Nutr Biochem 19, 778-784.
27. Wagner JD, Cefalu WT, Anthony MS, et al. (1997) Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgus monkeys. Metabolism 46, 698-705.
28. Lee JS (2006) Effects of soy protein and genistein on blood glucose, antioxidant enzyme activities, and lipid profile in strep-tozotocin-induced diabetic rats. Life Sci 79, 1578-1584.
29. Davis J, Higginbotham A, O'Connor T, et al. (2007) Soy protein and isoflavones influence adiposity and development of metabolic syndrome in the obese male ZDF rat. Ann Nutr Metab 51, 42-52.
30. Ishihara K, Oyaizu S, Fukuchi Y, et al. (2003) A soybean peptide isolate diet promotes postprandial carbohydrate oxidation and energy expenditure in type II diabetic mice. J Nutr 133, 752-757.
31. Nordentoft I, Jeppesen PB, Hong J, et al. (2008) Increased insulin sensitivity and changes in the expression profile of key insulin regulatory genes and beta cell transcription factors in diabetic KKAy-mice after feeding with a soy bean protein rich diet high in isoflavone content. J Agric Food Chem 56, 4377-4385.
32. Ae Park S, Choi MS, Cho SY, et al. (2006) Genistein and daid-zein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db mice. Life Sci 79, 1207-1213.
33. Teixeira SR, Tappenden KA, Carson L, et al. (2004) Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy. J Nutr 134, 1874-1880.
34. Azadbakht L, Atabak S & Esmaillzadeh A (2008) Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial. Diabetes Care 31, 648-654.
35. Azadbakht L, Shakerhosseini R, Atabak S, et al. (2003) Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy. Eur J Clin Nutr 57, 1292-1294.
36. Anderson JW, Blake JE, Turner J, et al. (1998) Effects of soy protein on renal function and proteinuria in patients with type 2 diabetes. Am J Clin Nutr 68, 1347S-1353S.
37. Oh HY, Kim SS, Chung HY, et al. (2005) Isoflavone supplements exert hormonal and antioxidant effects in post-menopausal Korean women with diabetic retinopathy. J Med Food 8, 1-7.
38. Li Z, Hong K, Saltsman P, et al. (2005) Long-term efficacy of soy-based meal replacements vs an individualized diet plan in obese type II DM patients: relative effects on weight loss, metabolic parameters, and C-reactive protein. Eur J Clin Nutr 59, 411-418.
39. Hermansen K, Sondergaard M, Hoie L, et al. (2001) Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care 24, 228-233.
40. Howes JB, Tran D, Brillante D, et al. (2003) Effects of dietary supplementation with isoflavones from red clover on ambulatory blood pressure and endothelial function in postmenopausal type 2 diabetes. Diabetes Obes Metab 5, 325-332.
41. Mahalko JR, Sandstead HH, Johnson LK, et al. (1984) Effect of consuming fiber from corn bran, soy hulls, or apple powder on glucose tolerance and plasma lipids in type II diabetes. Am J Clin Nutr 39, 25-34.
42. Ristic Medic D, Ristic V, Arsic A, et al. (2006) Effects of soybean D-LeciVita product on serum lipids and fatty acid composition in type 2 diabetic patients with hyperlipidemia. Nutr Metab Cardiovasc Dis 16, 395-404.
43. Shahbazian H, Reza A, Javad S, et al. (2007) Beneficial effects of soy protein isoflavones on lipid and blood glucose concentrations in type 2 diabetic subjects. Saudi Med J 28, 652-654.
44. Tsai AC, Vinik AI, Lasichak A, et al. (1987) Effects of soy polysaccharide on postprandial plasma glucose, insulin, glucagon, pancreatic polypeptide, somatostatin, and triglyceride in obese diabetic patients. Am J Clin Nutr 45, 596-601.
45. Gonzalez S, Jayagopal V, Kilpatrick ES, et al. (2007) Effects of isoflavone dietary supplementation on cardiovascular risk factors in type 2 diabetes. Diabetes Care 30, 1871-1873.
46. Jayagopal V, Albertazzi P, Kilpatrick ES, et al. (2002) Beneficial effects of soy phytoestrogen intake in postmenopau-sal women with type 2 diabetes. Diabetes Care 25, 1709-1714.
47. Gannon MC, Nuttall FQ, Saeed A, et al. (2003) An increase in dietary protein improves the blood glucose response in persons with type 2 diabetes. Am J Clin Nutr 78, 734-741.
48. Gannon MC & Nuttall FQ (2006) Control of blood glucose in type 2 diabetes without weight loss by modification of diet composition. Nutr Metab (Lond) 3, 16.
49. Layman DK, Clifton P, Gannon MC, et al. (2008) Protein in optimal health: heart disease and type 2 diabetes. Am J Clin Nutr 87, 1571S-1575S.
50. Lampe JW, Skor HE, Li S, et al. (2001) Wheat bran and soy protein feeding do not alter urinary excretion of the isoflavan equol in premenopausal women. J Nutr 131, 740-744.
51. Muniyappa R, Lee S, Chen H, et al. (2008) Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 294, E15-E26.
52. Chen H, Sullivan G & Quon MJ (2005) Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model. Diabetes 54, 1914-1925.
53. Phillips DI, Clark PM, Hales CN, et al. (1994) Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med 11, 286-292.
54. Rowland IR, Wiseman H, Sanders TA, et al. (2000) Interindivi-dual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut micro-flora. Nutr Cancer 36, 27-32.
55. Markovic TP, Jenkins AB, Campbell LV, et al. (1998) The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM. Diabetes Care 21, 687-694.
56. Pittas AG, Lau J, Hu FB, et al. (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-anal-ysis. J Clin Endocrinol Metab 92, 2017-2029.
57. Xu X, Duncan AM, Merz BE, et al. (1998) Effects of soy iso-flavones on estrogen and phytoestrogen metabolism in premeno-pausal women. Cancer Epidemiol Biomarkers Prev 7, 1101-1108.
58. Lampe JW, Karr SC, Hutchins AM, et al. (1998) Urinary equol excretion with a soy challenge: influence of habitual diet. Proc Soc Exp Biol Med 217, 335-339.
59. Kelly GE, Nelson C, Waring MA, et al. (1993) Metabolites of dietary (soya) isoflavones in human urine. Clin Chim Acta 223, 9-22.
60. Hall WL, Vafeiadou K, Hallund J, et al. (2006) Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr 83, 592-600.
61. von Hertzen L, Forsblom C, Stumpf K, et al. (2004) Highly elevated serum phyto-oestrogen concentrations in patients with diabetic nephropathy. J Intern Med 255, 602-609.
62. American Diabetes Association (ADA) (2002) Tests of glycemia in diabetes. Position statement. Diabetes Care 25, S97-S99.
63. Heilbronn LK, Noakes M & Clifton PM (2002) The effect of high-and low-glycemic index energy restricted diets on plasma lipid and glucose profiles in type 2 diabetic subjects with varying glycemic control. J Am Coll Nutr 21, 120-127.
64. Azadbakht L, Kimiagar M, Mehrabi Y, et al. (2007) Soy inclusion in the diet improves features of the metabolic syndrome: a randomized crossover study in postmenopausal women. Am J Clin Nutr 85, 735-741.
65. Avignon A, Radauceanu A & Monnier L (1997) Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care 20, 1822-1826.
66. Kang MJ, Kim JI, Yoon SY, et al. (2006) Pinitol from soybeans reduces postprandial blood glucose in patients with type 2 diabetes mellitus. J Med Food 9, 182-186.
67. Harris SB, Ekoe JM, Zdanowicz Y, et al. (2005) Glycemic control and morbidity in the Canadian primary care setting (results of the diabetes in Canada evaluation study). Diabetes Res Clin Pract 70, 90-97.